<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TLR4 Adjuvant &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tlr4-adjuvant/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 13 Dec 2025 00:09:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>TLR4 Adjuvant &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>c-di-GMP Boosts TLR4 Vaccine Efficacy Against Tuberculosis</title>
		<link>https://bioengineer.org/c-di-gmp-boosts-tlr4-vaccine-efficacy-against-tuberculosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 13 Dec 2025 00:09:05 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[c-di-GMP]]></category>
		<category><![CDATA[immune response]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **Tuberculosis Vaccine]]></category>
		<category><![CDATA[TLR4 Adjuvant]]></category>
		<category><![CDATA[Vaccine Efficacy** **Açıklama:** 1. **Tuberculosis Vaccine:** Makalenin temel konusu tüberküloz aşısı geliştirilmesidir. 2. **c-di-GMP:** Araştırmanın odağında olan]]></category>
		<guid isPermaLink="false">https://bioengineer.org/c-di-gmp-boosts-tlr4-vaccine-efficacy-against-tuberculosis/</guid>

					<description><![CDATA[In a significant advancement in the field of infectious disease prevention, researchers have turned their sights toward tuberculosis (TB), one of the deadliest diseases worldwide. With millions affected each year, the development of an effective vaccine remains a major public health priority. In a groundbreaking study, a team led by Kwon et al. has unveiled [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">307028</post-id>	</item>
	</channel>
</rss>
